Digestive system cancers, including hepatobiliary and gastrointestinal malignancies, remain a major global oncological burden ...

Biomarker testing in colorectal cancer (CRC) informs doctors about unique features of cancer that may influence its growth, spread, recurrence, and treatment response. Colorectal cancer (CRC), which ...

Metastatic breast cancer subtypes and biomarkers are crucial for guiding treatment decisions and managing disease progression. ER-positive, HER2-negative breast cancer treatment often begins with ...

A Northwestern Medicine study has offered new clues as to why immunotherapy works well for some bladder cancer patients but fails for others, according to a study published in the Journal of Clinical ...

Region-specific biomarkers FGFR4, FLT1, and WNT5A are linked to tumor behavior and therapeutic response in CRC. Comprehensive genomic profiling (CGP) aids in precision medicine by identifying genetic ...

Gastric cancer remains one of the leading causes of cancer mortality worldwide, largely as a result of late‐stage diagnosis and heterogeneity in tumour biology. Circulating biomarkers have emerged as ...

Learn why comprehensive biomarker testing is essential before starting any lung cancer treatment. Hear from patients and ...

Researchers at Mayo Clinic have developed an artificial intelligence (AI) system that could transform how pancreatic cancer ...

Translational cancer biomarker research helps convert molecular profiles into potentially clinically relevant insights. Achieving this goal requires integrated workflows that connect unbiased ...

Early detection and prevention of cancer can save lives, but current tools often fall short because of suboptimal accuracy and limited accessibility. The Fred Hutch Cancer Center aims to change that ...